Christian T Ruff MD
Cardiovascular Disease Genetics
Director of General Cardiology, Brigham and Women's Hospital; Senior Investigator, TIMI Study Group; Associate Professor of Medicine, Harvard Medical School
Join to View Full Profile
75 Francis StBrigham & Women's HospitalBoston, MA 02115
Phone+1 617-732-6660
Dr. Ruff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's HospitalFellowship, Cardiovascular Disease, 2006 - 2009- Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2003 - 2006
Johns Hopkins University School of MedicineClass of 2003
Certifications & Licensure
MA State Medical License 2005 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- Long-term visit-to-visit blood pressure variability and risk of cardiovascular and bleeding events: insights from the ENGAGE AF-TIMI 48 trial.Riccardo Proietti, Michael Gerard Palazzolo, Christian T Ruff, Gregory Y H Lip, Robert P Giugliano
Hypertension Research. 2025-04-01 - Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism.Davide Capodanno, John H Alexander, M Cecilia Bahit, John W Eikelboom, C Michael Gibson
Nature Reviews. Cardiology. 2025-03-31 - 1 citationsBiomarker-Based Model for Prediction of Ischemic Stroke in Patients With Atrial Fibrillation.Lars Wallentin, Johan Lindbäck, Ziad Hijazi, Jonas Oldgren, Anthony P Carnicelli
Journal of the American College of Cardiology. 2025-03-25
Journal Articles
- Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesStephen D Wiviott, Marc S Sabatine, Christian T Ruff, Marc P Bonaca, Deepak L Bhatt, Darren K McGuire, The New England Journal of Medicine
- Cardiovascular Safety of Lorcaserin in Overweight or Obese PatientsErin A Bohula, Stephen D Wiviott, Benjamin M Scirica, Darren K McGuire, Marc S Sabatine, Marc P Bonaca, Christian T Ruff, Silvio E Inzucchi, The New England Journal of Medicine
Press Mentions
Study Demonstrates Abelacimab Significantly Reduced Bleeding in Patients Regardless of Age, Bleeding RiskMarch 31st, 2025- Study Shows Abelacimab Significantly Reduced Bleeding vs. Standard DOACJanuary 24th, 2025
- Fewer Bleeding Events Seen with Abelacimab Than Rivaroxaban in a-fibJanuary 24th, 2025
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
